Join BOPA
Back to news articles

BOPA Members Honoured as Fellows of Royal Pharmaceutical Society

By BOPA on 27th May 2024

Two BOPA members have been appointed as Fellows of the Royal Pharmaceutical Society (FRPharmS) for Distinction in Profession of Pharmacy in the latest appointment announced by the RPS Panel of Fellows on 24th May 2024.

https://www.rpharms.com/about-us/news/details/new-rps-fellows-may-2024

Professor Nicola Stoner fBOPA, appointed BOPA Fellow in 2023.

Joseph Williams mBOPA, BOPA Chair

 

Congratulation to Nicola and Joe for their recognition, both of them have been driving forces in BOPA’s continuous effort in promoting excellence in the pharmaceutical care of patients with cancer.

Richly-deserved achievements!

Latest News

By BOPA Committee on 3rd May 2025

Let’s Talk About SACT podcast has been featured in the TOP 40 pharmacology Podcasts worldwide

The BOPA podcast team (Michal Sladkowski, Chiara Creed and Eleanor Meerstadt) are thrilled to share that the Let’s Talk About SACT podcast has been featured in the TOP 40 pharmacology…

Read article
By BOPA Education & Training Subcommittee on 3rd May 2025

NEW eLearning module for Myeloma now live

Dear BOPA members,   The Education and Training subcommittee are pleased to announce that our new e-learning module for myeloma is now live on the BOPA website. The module can…

Read article
By BOPA Research Committee on 27th April 2025

SURVEY: Understanding Clinicians’ perceptions of a Decision Support tool for Lung Cancer Treatment

Dear BOPA member, Tarini Deleep and Dr Pinkie Chambers from University College London are developing a risk prediction model to help identify patients with incurable Non Small Cell Lung Cancer,…

Read article
By BOPA on 27th April 2025

Further monographs for use of immunosuppressants in Immune-related adverse events (irAEs)

Earlier this year the BOPA Immunotherapy Group wrote, and published, four monographs to help health care professionals care for patients with immune-related adverse events. As a group we are pleased…

Read article